Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Vestmark Advisory Solutions Inc. boosted its stake in shares of Equifax Inc. (NYSE:EFX – Get Rating) by 4.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,985 shares of the credit services provider’s stock after acquiring an additional 1,205 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Equifax were worth $4,969,000 as of its most recent SEC filing.
→ America’s Energy Armageddon (From Porter & Company)document.write(‘
‘);
Several other large investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Equifax by 1.2% during the first quarter. Vanguard Group Inc. now owns 13,036,468 shares of the credit services provider’s stock worth $3,090,947,000 after acquiring an additional 155,572 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Equifax by 6.2% during the second quarter. Massachusetts Financial Services Co. MA now owns 12,546,483 shares of the credit services provider’s stock worth $2,293,245,000 after acquiring an additional 737,642 shares during the last quarter. FMR LLC increased its stake in Equifax by 14.2% during the second quarter. FMR LLC now owns 4,650,733 shares of the credit services provider’s stock worth $850,060,000 after acquiring an additional 579,519 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in Equifax by 29.6% during the second quarter. Price T Rowe Associates Inc. MD now owns 4,160,261 shares of the credit services provider’s stock worth $760,413,000 after acquiring an additional 949,408 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in Equifax by 0.6% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,408,679 shares of the credit services provider’s stock worth $440,258,000 after acquiring an additional 13,532 shares during the last quarter. 93.84% of the stock is owned by institutional investors.
Equifax Stock Down 0.4 %
Shares of EFX stock traded down $0.84 during trading hours on Thursday, reaching $216.78. 27,316 shares of the company’s stock were exchanged, compared to its average volume of 710,825. The stock’s 50 day moving average is $199.58 and its 200-day moving average is $191.18. The company has a market cap of $26.54 billion, a price-to-earnings ratio of 37.78 and a beta of 1.42. The company has a current ratio of 0.64, a quick ratio of 0.64 and a debt-to-equity ratio of 1.28. Equifax Inc. has a fifty-two week low of $145.98 and a fifty-two week high of $245.27.
Equifax (NYSE:EFX – Get Rating) last issued its quarterly earnings results on Wednesday, October 19th. The credit services provider reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.09. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.21 billion. Equifax had a return on equity of 25.88% and a net margin of 13.72%. The business’s quarterly revenue was up 1.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.85 earnings per share. Analysts predict that Equifax Inc. will post 7.53 earnings per share for the current fiscal year.
Equifax Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, December 15th. Stockholders of record on Wednesday, November 23rd were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date was Tuesday, November 22nd. Equifax’s payout ratio is presently 27.08%.
Insider Transactions at Equifax
In other news, Director Melissa D. Smith bought 672 shares of the business’s stock in a transaction that occurred on Friday, October 21st. The shares were purchased at an average cost of $148.69 per share, with a total value of $99,919.68. Following the transaction, the director now directly owns 3,474 shares in the company, valued at $516,549.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Mark W. Begor sold 11,000 shares of the company’s stock in a transaction on Wednesday, October 26th. The stock was sold at an average price of $165.51, for a total value of $1,820,610.00. Following the transaction, the chief executive officer now directly owns 92,918 shares of the company’s stock, valued at approximately $15,378,858.18. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Melissa D. Smith bought 672 shares of the business’s stock in a transaction that occurred on Friday, October 21st. The stock was purchased at an average cost of $148.69 per share, for a total transaction of $99,919.68. Following the completion of the transaction, the director now owns 3,474 shares in the company, valued at $516,549.06. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 31,100 shares of company stock valued at $5,146,968. Corporate insiders own 1.57% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have issued reports on EFX. Royal Bank of Canada lowered Equifax from an “outperform” rating to a “sector perform” rating and dropped their target price for the company from $195.00 to $158.00 in a research report on Thursday, October 20th. Atlantic Securities upgraded Equifax from a “neutral” rating to an “overweight” rating and set a $230.00 target price for the company in a research report on Tuesday, November 15th. Wells Fargo & Company boosted their target price on Equifax from $165.00 to $210.00 and gave the company an “equal weight” rating in a research report on Friday, January 13th. Morgan Stanley boosted their target price on Equifax from $192.00 to $197.00 and gave the company an “equal weight” rating in a research report on Wednesday, January 4th. Finally, Barclays boosted their target price on Equifax from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, December 2nd. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $206.13.
About Equifax
(Get Rating)
Equifax, Inc engages in the provision of information solutions and human resources business process outsourcing services. It operates through the following business segments: U.S. Information Solutions, Workforce Solutions and International. The U.S. Information Solutions segment includes consumer and commercial information services, mortgage loan origination information, financial marketing services, and identity management.
Featured Stories
- Get a free copy of the StockNews.com research report on Equifax (EFX)
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
- Microsoft Layoffs Signal Layoffs for Other Tech Companies?
- More Than One Reason To Buy Fastenal, Quickly
- 3 Attractive Defensive Stocks With 3% Dividends
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax Inc. (NYSE:EFX – Get Rating).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Equifax, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Equifax wasn’t on the list.
While Equifax currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by entering your email address below.
Which stocks are major institutional investors including hedge funds and endowments buying in today’s market? Enter your email address below and we’ll send you MarketBeat’s list of thirteen stocks that institutional investors are buying up as quickly as they can.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
As Featured By:
326 E 8th St #105, Sioux Falls, SD 57103
contact@marketbeat.com
(844) 978-6257
© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.
© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.